The Korean Journal of Critical Care Medicine 1998;13(2):254-260
Successful Coronary Interventions with the Aid of Abciximab (ReoPro (R)) in High-Risk Patients: Report of Two Cases.
Woo Suck PARK 1 ; Myung Ho JEONG ; Nam Ho KIM ; Young Keun AHN ; Youl BAE ; Gwang Chae GILL ; Joo Hyung PARK ; Jeong Gwan CHO ; Jong Chun PARK ; Jung Chaee KANG
Affiliations
Keywords
High risk patient; Coronary intervention; Abciximab
Country
Republic of Korea
Language
Korean
MeSH
ACTIONS
ACTIONS
ACTIONS
ACTIONS
Abstract
Abrupt closure of coronary artery during coronary intervention is one of major limitations especially in high-risk patients. Platelets are responsible for composing acute thrombotic occlusion at the site of therapeutic arterial injury. Abciximab (platelet glycoprotein IIb/IIIa receptor blocker) might be helpful in preventing the acute thrombotic occlusion. We experienced an excellent effects of the drug in two cases of high-risk patients, unsuccessful thrombolytics and PTCA with acute occlusion. With additional use of abciximab we overcame the complications and succeeded in getting normal coronary flow and resultant successful angioplasties.
备案号: 11010502037788, 京ICP备10218182号-8)